MANCHESTER: Yourgene Health, a leading international molecular diagnostics group, has entered into a 5-year strategic partnership with a blue chip Japanese multinational to provide Yourgene’s Flex Analysis Software bioinformatics platform for a reproductive health project. Yourgene and the Japanese partner have entered into a technology transfer agreement which provides the Partner with access to Yourgene’s…
MANCHESTER: Yourgene Health Plc, a leading international molecular diagnostics group, announced a collaboration agreement with international payments company Caxton and immunity passport app Prova, which once launched will support the efforts to get Britain back to work by testing employees for COVID-19. The collaboration with Prova and Yourgene will enable Caxton to offer COVID-19 tests…
MANCHESTER: Yourgene Health, an international molecular diagnostics group, announced that its chemotoxicity diagnostics assay – Elucigene DPYD – which tests to identify cancer patients at risk of lethal side effects from chemotherapy, has been approved for sale in Australia by the Therapeutic Goods Administration (TGA) as an IVD (in vitro diagnostic). The TGA is the…